MarketBeat provided ratings, Renaissance Technologies raised its stake, Millennium Management increased its stake, and Citigroup began coverage on Biomea Fusion stock.
3 reports, 1 independent
Updated Oct 8
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided ratings, Renaissance Technologies raised its stake, Millennium Management increased its stake, and Citigroup began coverage on Biomea Fusion stock.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.RT increased stake in Biomea Fusion; Citigroup restated outperform rating.1 source
Multiple investment firms initiated coverage and increased stakes in Biomea Fusion.1 source
Keep exploring
The entities involved
-
Renaissance Technologies
American hedge fund firm
-
Millennium Management
alternative investment management firm
Nothing else this week.
-
Citigroup
American investment bank and financial services corporation
Related events
- MarketBeat is aggregating information about Entera Bio Ltd., noting that Renaissance Technologies is a major institutional investor and the company trades on the Nasdaq stock exchange.
- MarketBeat provided average rating data for the stock, and Citigroup began coverage on Whitehawk Therapeutics shares.
- Citigroup raised Magazine Luiza rating to buy, while MarketBeat provided consensus rating data.
- MarketBeat aggregates consensus rating data on Aegon, while Citigroup weighed in and Morgan Stanley downgraded the rating.
- Citigroup reiterated a market perform rating, Bank of America restated an underperform rating, and Raymond James Financial started coverage for Omega Healthcare Investors, Inc.